Broek Richard van den
CIK 1431872 · last filed 2025-08-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
66
Lifetime Open-Market Net
$168.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLSE | Director | — | $24.37 | — | $0 | 6 | 2025-08-19 |
| CRVS | Director | — | $11.93 | — | $0 | 1 | 2025-04-09 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 5 | 2022-05-20 |
| RESPONSE GENETICS INC (RGDX) Delisted | Director | 282,700 | — | — | $150.0K | 7 | 2014-07-11 |
| STANDARD DIVERSIFIED INC. (SDIX) Delisted | Director | 235,630 | — | — | $18.6K | 8 | 2012-05-17 |
Recent Filings · Page 2 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-05 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-13 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-01 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-09 | — | Grant (A) | +10,000 | $0 | |
| 2015-06-25 | — | Grant (A) | +2,500 | $0 | |
| 2015-06-11 | — | Grant (A) | +6,500 | $0 | |
| 2015-05-28 | — | Mixed | −29,610 | -$7.74M | |
| 2015-04-09 | — | Grant (A) | — | $0 | |
| 2015-01-06 | — | Grant (A) | — | $0 | |
| 2014-12-30 | — | Sell (S) | −75,000 | -$83.6K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.